Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage.

International journal of molecular medicine

Volumn 5, Issue 6, 2000, Pages 597-604

  Feng, L ^a   Achanta, G ^a   Pelicano, H ^a   Zhang, W ^a   Plunkett, W ^a   Huang, P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUDARABINE; GEMCITABINE; PROTEIN P53; THYMIDINE; VIDARABINE;

ARTICLE; DNA DAMAGE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DEOXYCYTIDINE; DNA DAMAGE; THYMIDINE; TUMOR SUPPRESSOR PROTEIN P53; VIDARABINE;

MLCS; MLOWN;

EID: 0034200867     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.5.6.597     Document Type: Article

References (0)